Central Plains Bancshares, Inc. Common Stock
NASDAQ:CPBIShell Companies
-$0.18 today
- Market cap
- $85.57M
- Beta
- 0.21
- P/E (TTM)
- 18.0
- EPS (TTM)
- $1.03
Volume 0.00M
Average 0.00M
CPBI Accounts Receivables
Cash effect of the change in amounts owed by customers; growing receivables consume cash.
Central Plains Bancshares, Inc. Common StockNASDAQ: CPBI
Accounts Receivables · Q3 FY2025 · quarter ended Dec 2025
Accounts receivables turns positive
Q3 FY2025 accounts receivables was $491K, compared with -$183K a year earlier. Trailing-twelve-month accounts receivables was -$459K.
Context
- Accounts receivables amounted to 3.1% of revenue in FY2024, up 0.9 pp from a year earlier.
- Accounts receivables increased in 0 of the last 3 fiscal years.
- FY2024 was the lowest annual figure in the 4 fiscal years shown.
What to watch
Whether quarterly accounts receivables holds near $491K or moves back toward the trailing-twelve-month quarterly average of -$114.75K.
Sources:Cash FlowText generated from reported figures; not investment advice.
Accounts Receivables history
USD · from the cash flow
- Latest · FY2024
- (852K) USD
- Year-over-year change
- -63.2%
| Period | Period end | Accounts Receivables | YoY change |
|---|---|---|---|
| FY2024 | 2025-03-31 | (852K) | -63.2% |
| FY2023 | 2024-03-31 | (522K) | -36.6% |
| FY2022 | 2023-03-31 | (382K) | — |
| FY2021 | 2022-03-31 | 0 | — |
Accounts Receivables vs competitors
How CPBI compares with its peers on the latest reported figures
- CPBI's LTM Dec 2025 accounts receivables of $459K is the 2nd largest of the 8 companies compared; the peer median is $0.
- Its year-over-year change of -36.6% is the 3rd highest of 5, against a peer median of +80.6%.
- Accounts receivables amounts to 1.5% of revenue for CPBI, versus a peer median of 0.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Mar 2026 | $4.35M | +261.1% | +1.2% | 79.6% | |
| LTM Dec 2025 | $459K | -36.6% | — | 1.5% | |
| LTM Mar 2026 | $326K | -184.7% | -10.3% | 0.5% | |
| LTM Mar 2026 | $294K | +764.7% | -22.3% | 0.5% | |
ORIQUOrigin Investment Corp I Units | FY2025 | $0 | — | — | — |
| LTM Mar 2026 | $0 | — | — | — | |
AFJKAimei Health Technology Co., Ltd | LTM Mar 2026 | $0 | -100.0% | — | — |
| LTM Mar 2026 | $0 | — | — | — | |
| Peer median (excluding CPBI) | $0 | +80.6% | -10.3% | 0.5% | |
Competitors are the stored peer set for CPBI. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Cash Flow Statement
Metric | FY2021 Mar 2022 | FY2022 Mar 2023 | FY2023 Mar 2024 | FY2024 Mar 2025 |
|---|---|---|---|---|
| Net Income | 3.15M | 1.65M | 3.76M | 3.65M |
| Depreciation & Amortization | 497K | 503K | 518K | 455K |
| Deferred Income Tax | 237K | 78K | 46K | 255K |
| Stock-Based Compensation | 0 | 0 | 161K | 360K |
| Change in Working Capital | (391K) | (1.54M) | 376K | (1.14M) |
| Accounts Receivables | 0 | (382K) | (522K) | (852K) |
| Inventory | 0 | 0 | 0 | 0 |
| Accounts Payables | 0 | (1.45M) | 684K | (693K) |
| Other Working Capital | (391K) | 300K | 214K | 409K |
| Other Non-Cash Items | 785K | 3.78M | 848K | 871K |
| Operating Cash Flow | 4.28M | 4.47M | 5.71M | 4.46M |
| Capital Expenditures | (255K) | (303K) | (2.28M) | (7.53M) |
| Acquisitions (Net) | 0 | 0 | 0 | 0 |
| Purchases of Investments | (23.34M) | (63K) | (11.56M) | (6.2M) |
| Sales of Investments | 27.56M | 12.05M | 9.15M | 8.42M |
| Other Investing Activities | (52.46M) | (44.61M) | (26.46M) | (22.6M) |
| Investing Cash Flow | (48.49M) | (32.93M) | (31.16M) | (27.9M) |
| Debt Repayment | 645K | 0 | (3.31M) | 238K |
| Common Stock Issued | 0 | 0 | 39.36M | 0 |
| Common Stock Repurchased | 0 | 0 | 0 | (413K) |
| Dividends Paid | 0 | 0 | 0 | 0 |
| Other Financing Activities | 35.4M | 26.04M | (15.72M) | 40.85M |
| Financing Cash Flow | 36.04M | 26.04M | 20.34M | 40.67M |
| Effect of Forex Changes | 0 | 0 | 0 | 0 |
| Net Change in Cash | (8.17M) | (2.42M) | (5.11M) | 17.23M |
| Free Cash Flow | 4.02M | 4.17M | 3.43M | (3.07M) |
Central Plains Bancshares, Inc. Common Stock
NASDAQ:CPBI
Intrinsic Alpha fair value
Locked
Current Price
$20.51
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.